Cellectar Biosciences Inc... (CLRB)
NASDAQ: CLRB
· Real-Time Price · USD
4.65
0.31 (7.14%)
At close: Aug 18, 2025, 3:59 PM
4.50
-3.23%
After-hours: Aug 18, 2025, 07:17 PM EDT
7.14% (1D)
| Bid | 4.28 |
| Market Cap | 12.45M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -24.54M |
| EPS (ttm) | -18.9 |
| PE Ratio (ttm) | -0.25 |
| Forward PE | -0.36 |
| Analyst | Buy |
| Ask | 4.88 |
| Volume | 380,008 |
| Avg. Volume (20D) | 496,819 |
| Open | 4.42 |
| Previous Close | 4.34 |
| Day's Range | 4.42 - 4.92 |
| 52-Week Range | 4.22 - 68.70 |
| Beta | 0.42 |
About CLRB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLRB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CLRB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-31.65%
Cellectar Biosciences shares are trading lower aft...
Unlock content with
Pro Subscription
2 months ago
+16.58%
Cellectar Biosciences shares are trading higher after the company announced initial results from the CLOVER-2 Phase 1 clinical trial evaluating iopofosine I 131 in relapsed/refractory pediatric high-grade glioma patients.
